Global Blood-based Cancer Screening Tests Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Blood-based Cancer Screening Tests market size was valued at US$ 4643 million in 2025 and is forecast to a readjusted size of US$ 16079 million by 2032 with a CAGR of 19.7% during review period.
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
This report is a detailed and comprehensive analysis for global Blood-based Cancer Screening Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood-based Cancer Screening Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood-based Cancer Screening Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Blood-based cancer screening tests use peripheral blood signals such as circulating free DNA, circulating tumor DNA, methylation patterns, protein biomarkers, fragmentomics or multi-omics features to identify early cancer risk in asymptomatic or high-risk populations. These tests may target a single cancer type or multiple cancers and emphasize minimally invasive sampling, adherence, early detection capability, management pathways for positive and negative results and clinical validation evidence. They are commonly used in health check-ups, hospital screening, public health programs and high-risk population follow-up. The average gross profit margin of this product is 55%.
The blood-based cancer screening market is being driven by demand for early cancer detection, upgrades to colorectal cancer screening tools and accumulating clinical evidence for multi-cancer early detection. Blood sampling offers high adherence and is suitable for health check-up centers, hospital outpatient settings and high-risk population management.
Major technical routes include cfDNA methylation, multi-omics modeling, ctDNA mutation detection and protein marker combinations. Key competitive factors are early-stage sensitivity, specificity, tissue-of-origin capability, validation cohort size and cost control. Blood-based colorectal cancer tests have one of the clearest commercialization paths, while multi-cancer early detection still requires more real-world evidence.
Market adoption is affected by regulatory approval, inclusion in clinical guidelines, payment systems and the cost of managing false positives. Future growth will depend on results from large prospective studies, reimbursement by public or commercial payers, lower testing costs and clear positioning alongside established screening pathways.
This report is a detailed and comprehensive analysis for global Blood-based Cancer Screening Tests market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Blood-based Cancer Screening Tests market size and forecasts, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Blood-based Cancer Screening Tests market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Blood-based Cancer Screening Tests
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Blood-based Cancer Screening Tests market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single-cancer Screening
- Multi-cancer Early Detection
- Colorectal Cancer Screening
- Liver Cancer Screening
- Lung Cancer Screening
- Risk Stratification Test
- Other
- cfDNA Methylation
- ctDNA Mutation
- Fragmentomics
- Protein Biomarkers
- Multi-omics
- Exosome-based
- Other
- Laboratory-developed Test
- IVD Kit
- Sequencing-based
- PCR-based
- Immunoassay-based
- Other
- Health Check-up Centers
- Hospitals
- Independent Clinical Laboratories
- Other
- GRAIL
- Guardant Health
- Exact Sciences
- Freenome
- Natera
- Foresight Diagnostics
- Burning Rock Biotech
- Genetron Health
- Singlera Genomics
- Berry Oncology
- Helio Genomics
- Sysmex
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
- Chapter 1, to describe Blood-based Cancer Screening Tests product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top players of Blood-based Cancer Screening Tests, with revenue, gross margin, and global market share of Blood-based Cancer Screening Tests from 2021 to 2026.
- Chapter 3, the Blood-based Cancer Screening Tests competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
- Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Blood-based Cancer Screening Tests market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
- Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
- Chapter 12, the key raw materials and key suppliers, and industry chain of Blood-based Cancer Screening Tests.
- Chapter 13, to describe Blood-based Cancer Screening Tests research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood-based Cancer Screening Tests by Type
1.3.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Type in 2025
1.3.3 Single-cancer Screening
1.3.4 Multi-cancer Early Detection
1.3.5 Colorectal Cancer Screening
1.3.6 Liver Cancer Screening
1.3.7 Lung Cancer Screening
1.3.8 Risk Stratification Test
1.3.9 Other
1.4 Classification of Blood-based Cancer Screening Tests by Biomarker
1.4.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Biomarker: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Biomarker in 2025
1.4.3 cfDNA Methylation
1.4.4 ctDNA Mutation
1.4.5 Fragmentomics
1.4.6 Protein Biomarkers
1.4.7 Multi-omics
1.4.8 Exosome-based
1.4.9 Other
1.5 Classification of Blood-based Cancer Screening Tests by Test Format
1.5.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Test Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Test Format in 2025
1.5.3 Laboratory-developed Test
1.5.4 IVD Kit
1.5.5 Sequencing-based
1.5.6 PCR-based
1.5.7 Immunoassay-based
1.5.8 Other
1.6 Global Blood-based Cancer Screening Tests Market by Application
1.6.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Health Check-up Centers
1.6.3 Hospitals
1.6.4 Independent Clinical Laboratories
1.6.5 Other
1.7 Global Blood-based Cancer Screening Tests Market Size & Forecast
1.8 Global Blood-based Cancer Screening Tests Market Size and Forecast by Region
1.8.1 Global Blood-based Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Blood-based Cancer Screening Tests Market Size by Region, (2021-2032)
1.8.3 North America Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.4 Europe Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.6 South America Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GRAIL
2.1.1 GRAIL Details
2.1.2 GRAIL Major Business
2.1.3 GRAIL Blood-based Cancer Screening Tests Product and Solutions
2.1.4 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GRAIL Recent Developments and Future Plans
2.2 Guardant Health
2.2.1 Guardant Health Details
2.2.2 Guardant Health Major Business
2.2.3 Guardant Health Blood-based Cancer Screening Tests Product and Solutions
2.2.4 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Guardant Health Recent Developments and Future Plans
2.3 Exact Sciences
2.3.1 Exact Sciences Details
2.3.2 Exact Sciences Major Business
2.3.3 Exact Sciences Blood-based Cancer Screening Tests Product and Solutions
2.3.4 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Exact Sciences Recent Developments and Future Plans
2.4 Freenome
2.4.1 Freenome Details
2.4.2 Freenome Major Business
2.4.3 Freenome Blood-based Cancer Screening Tests Product and Solutions
2.4.4 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Freenome Recent Developments and Future Plans
2.5 Natera
2.5.1 Natera Details
2.5.2 Natera Major Business
2.5.3 Natera Blood-based Cancer Screening Tests Product and Solutions
2.5.4 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Natera Recent Developments and Future Plans
2.6 Foresight Diagnostics
2.6.1 Foresight Diagnostics Details
2.6.2 Foresight Diagnostics Major Business
2.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Product and Solutions
2.6.4 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Foresight Diagnostics Recent Developments and Future Plans
2.7 Burning Rock Biotech
2.7.1 Burning Rock Biotech Details
2.7.2 Burning Rock Biotech Major Business
2.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Product and Solutions
2.7.4 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Burning Rock Biotech Recent Developments and Future Plans
2.8 Genetron Health
2.8.1 Genetron Health Details
2.8.2 Genetron Health Major Business
2.8.3 Genetron Health Blood-based Cancer Screening Tests Product and Solutions
2.8.4 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Genetron Health Recent Developments and Future Plans
2.9 Singlera Genomics
2.9.1 Singlera Genomics Details
2.9.2 Singlera Genomics Major Business
2.9.3 Singlera Genomics Blood-based Cancer Screening Tests Product and Solutions
2.9.4 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Singlera Genomics Recent Developments and Future Plans
2.10 Berry Oncology
2.10.1 Berry Oncology Details
2.10.2 Berry Oncology Major Business
2.10.3 Berry Oncology Blood-based Cancer Screening Tests Product and Solutions
2.10.4 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Berry Oncology Recent Developments and Future Plans
2.11 Helio Genomics
2.11.1 Helio Genomics Details
2.11.2 Helio Genomics Major Business
2.11.3 Helio Genomics Blood-based Cancer Screening Tests Product and Solutions
2.11.4 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Helio Genomics Recent Developments and Future Plans
2.12 Sysmex
2.12.1 Sysmex Details
2.12.2 Sysmex Major Business
2.12.3 Sysmex Blood-based Cancer Screening Tests Product and Solutions
2.12.4 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sysmex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood-based Cancer Screening Tests Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood-based Cancer Screening Tests by Company Revenue
3.2.2 Top 3 Blood-based Cancer Screening Tests Players Market Share in 2025
3.2.3 Top 6 Blood-based Cancer Screening Tests Players Market Share in 2025
3.3 Blood-based Cancer Screening Tests Market: Overall Company Footprint Analysis
3.3.1 Blood-based Cancer Screening Tests Market: Region Footprint
3.3.2 Blood-based Cancer Screening Tests Market: Company Product Type Footprint
3.3.3 Blood-based Cancer Screening Tests Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood-based Cancer Screening Tests Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood-based Cancer Screening Tests Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood-based Cancer Screening Tests Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
6.2 North America Blood-based Cancer Screening Tests Market Size by Application (2021-2032)
6.3 North America Blood-based Cancer Screening Tests Market Size by Country
6.3.1 North America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
6.3.2 United States Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
6.3.3 Canada Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
7.2 Europe Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
7.3 Europe Blood-based Cancer Screening Tests Market Size by Country
7.3.1 Europe Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
7.3.2 Germany Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.3 France Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.5 Russia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.6 Italy Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood-based Cancer Screening Tests Market Size by Region
8.3.1 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2021-2032)
8.3.2 China Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.3 Japan Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.5 India Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.7 Australia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
9.2 South America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
9.3 South America Blood-based Cancer Screening Tests Market Size by Country
9.3.1 South America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Country
10.3.1 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10.3.4 UAE Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood-based Cancer Screening Tests Market Drivers
11.2 Blood-based Cancer Screening Tests Market Restraints
11.3 Blood-based Cancer Screening Tests Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood-based Cancer Screening Tests Industry Chain
12.2 Blood-based Cancer Screening Tests Upstream Analysis
12.3 Blood-based Cancer Screening Tests Midstream Analysis
12.4 Blood-based Cancer Screening Tests Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Blood-based Cancer Screening Tests by Type
1.3.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Type in 2025
1.3.3 Single-cancer Screening
1.3.4 Multi-cancer Early Detection
1.3.5 Colorectal Cancer Screening
1.3.6 Liver Cancer Screening
1.3.7 Lung Cancer Screening
1.3.8 Risk Stratification Test
1.3.9 Other
1.4 Classification of Blood-based Cancer Screening Tests by Biomarker
1.4.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Biomarker: 2021 Versus 2025 Versus 2032
1.4.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Biomarker in 2025
1.4.3 cfDNA Methylation
1.4.4 ctDNA Mutation
1.4.5 Fragmentomics
1.4.6 Protein Biomarkers
1.4.7 Multi-omics
1.4.8 Exosome-based
1.4.9 Other
1.5 Classification of Blood-based Cancer Screening Tests by Test Format
1.5.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Test Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Test Format in 2025
1.5.3 Laboratory-developed Test
1.5.4 IVD Kit
1.5.5 Sequencing-based
1.5.6 PCR-based
1.5.7 Immunoassay-based
1.5.8 Other
1.6 Global Blood-based Cancer Screening Tests Market by Application
1.6.1 Overview: Global Blood-based Cancer Screening Tests Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Health Check-up Centers
1.6.3 Hospitals
1.6.4 Independent Clinical Laboratories
1.6.5 Other
1.7 Global Blood-based Cancer Screening Tests Market Size & Forecast
1.8 Global Blood-based Cancer Screening Tests Market Size and Forecast by Region
1.8.1 Global Blood-based Cancer Screening Tests Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Blood-based Cancer Screening Tests Market Size by Region, (2021-2032)
1.8.3 North America Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.4 Europe Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.6 South America Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Blood-based Cancer Screening Tests Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GRAIL
2.1.1 GRAIL Details
2.1.2 GRAIL Major Business
2.1.3 GRAIL Blood-based Cancer Screening Tests Product and Solutions
2.1.4 GRAIL Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GRAIL Recent Developments and Future Plans
2.2 Guardant Health
2.2.1 Guardant Health Details
2.2.2 Guardant Health Major Business
2.2.3 Guardant Health Blood-based Cancer Screening Tests Product and Solutions
2.2.4 Guardant Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Guardant Health Recent Developments and Future Plans
2.3 Exact Sciences
2.3.1 Exact Sciences Details
2.3.2 Exact Sciences Major Business
2.3.3 Exact Sciences Blood-based Cancer Screening Tests Product and Solutions
2.3.4 Exact Sciences Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Exact Sciences Recent Developments and Future Plans
2.4 Freenome
2.4.1 Freenome Details
2.4.2 Freenome Major Business
2.4.3 Freenome Blood-based Cancer Screening Tests Product and Solutions
2.4.4 Freenome Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Freenome Recent Developments and Future Plans
2.5 Natera
2.5.1 Natera Details
2.5.2 Natera Major Business
2.5.3 Natera Blood-based Cancer Screening Tests Product and Solutions
2.5.4 Natera Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Natera Recent Developments and Future Plans
2.6 Foresight Diagnostics
2.6.1 Foresight Diagnostics Details
2.6.2 Foresight Diagnostics Major Business
2.6.3 Foresight Diagnostics Blood-based Cancer Screening Tests Product and Solutions
2.6.4 Foresight Diagnostics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Foresight Diagnostics Recent Developments and Future Plans
2.7 Burning Rock Biotech
2.7.1 Burning Rock Biotech Details
2.7.2 Burning Rock Biotech Major Business
2.7.3 Burning Rock Biotech Blood-based Cancer Screening Tests Product and Solutions
2.7.4 Burning Rock Biotech Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Burning Rock Biotech Recent Developments and Future Plans
2.8 Genetron Health
2.8.1 Genetron Health Details
2.8.2 Genetron Health Major Business
2.8.3 Genetron Health Blood-based Cancer Screening Tests Product and Solutions
2.8.4 Genetron Health Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Genetron Health Recent Developments and Future Plans
2.9 Singlera Genomics
2.9.1 Singlera Genomics Details
2.9.2 Singlera Genomics Major Business
2.9.3 Singlera Genomics Blood-based Cancer Screening Tests Product and Solutions
2.9.4 Singlera Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Singlera Genomics Recent Developments and Future Plans
2.10 Berry Oncology
2.10.1 Berry Oncology Details
2.10.2 Berry Oncology Major Business
2.10.3 Berry Oncology Blood-based Cancer Screening Tests Product and Solutions
2.10.4 Berry Oncology Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Berry Oncology Recent Developments and Future Plans
2.11 Helio Genomics
2.11.1 Helio Genomics Details
2.11.2 Helio Genomics Major Business
2.11.3 Helio Genomics Blood-based Cancer Screening Tests Product and Solutions
2.11.4 Helio Genomics Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Helio Genomics Recent Developments and Future Plans
2.12 Sysmex
2.12.1 Sysmex Details
2.12.2 Sysmex Major Business
2.12.3 Sysmex Blood-based Cancer Screening Tests Product and Solutions
2.12.4 Sysmex Blood-based Cancer Screening Tests Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Sysmex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Blood-based Cancer Screening Tests Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Blood-based Cancer Screening Tests by Company Revenue
3.2.2 Top 3 Blood-based Cancer Screening Tests Players Market Share in 2025
3.2.3 Top 6 Blood-based Cancer Screening Tests Players Market Share in 2025
3.3 Blood-based Cancer Screening Tests Market: Overall Company Footprint Analysis
3.3.1 Blood-based Cancer Screening Tests Market: Region Footprint
3.3.2 Blood-based Cancer Screening Tests Market: Company Product Type Footprint
3.3.3 Blood-based Cancer Screening Tests Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Blood-based Cancer Screening Tests Consumption Value and Market Share by Type (2021-2026)
4.2 Global Blood-based Cancer Screening Tests Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2026)
5.2 Global Blood-based Cancer Screening Tests Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
6.2 North America Blood-based Cancer Screening Tests Market Size by Application (2021-2032)
6.3 North America Blood-based Cancer Screening Tests Market Size by Country
6.3.1 North America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
6.3.2 United States Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
6.3.3 Canada Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
6.3.4 Mexico Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
7.2 Europe Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
7.3 Europe Blood-based Cancer Screening Tests Market Size by Country
7.3.1 Europe Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
7.3.2 Germany Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.3 France Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.5 Russia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
7.3.6 Italy Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Blood-based Cancer Screening Tests Market Size by Region
8.3.1 Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2021-2032)
8.3.2 China Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.3 Japan Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.4 South Korea Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.5 India Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
8.3.7 Australia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
9.2 South America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
9.3 South America Blood-based Cancer Screening Tests Market Size by Country
9.3.1 South America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
9.3.2 Brazil Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
9.3.3 Argentina Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Blood-based Cancer Screening Tests Market Size by Country
10.3.1 Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2021-2032)
10.3.2 Turkey Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
10.3.4 UAE Blood-based Cancer Screening Tests Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Blood-based Cancer Screening Tests Market Drivers
11.2 Blood-based Cancer Screening Tests Market Restraints
11.3 Blood-based Cancer Screening Tests Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Blood-based Cancer Screening Tests Industry Chain
12.2 Blood-based Cancer Screening Tests Upstream Analysis
12.3 Blood-based Cancer Screening Tests Midstream Analysis
12.4 Blood-based Cancer Screening Tests Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Blood-based Cancer Screening Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood-based Cancer Screening Tests Consumption Value by Biomarker, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood-based Cancer Screening Tests Consumption Value by Test Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood-based Cancer Screening Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Blood-based Cancer Screening Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GRAIL Company Information, Head Office, and Major Competitors
Table 8. GRAIL Major Business
Table 9. GRAIL Blood-based Cancer Screening Tests Product and Solutions
Table 10. GRAIL Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GRAIL Recent Developments and Future Plans
Table 12. Guardant Health Company Information, Head Office, and Major Competitors
Table 13. Guardant Health Major Business
Table 14. Guardant Health Blood-based Cancer Screening Tests Product and Solutions
Table 15. Guardant Health Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Guardant Health Recent Developments and Future Plans
Table 17. Exact Sciences Company Information, Head Office, and Major Competitors
Table 18. Exact Sciences Major Business
Table 19. Exact Sciences Blood-based Cancer Screening Tests Product and Solutions
Table 20. Exact Sciences Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Freenome Company Information, Head Office, and Major Competitors
Table 22. Freenome Major Business
Table 23. Freenome Blood-based Cancer Screening Tests Product and Solutions
Table 24. Freenome Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Freenome Recent Developments and Future Plans
Table 26. Natera Company Information, Head Office, and Major Competitors
Table 27. Natera Major Business
Table 28. Natera Blood-based Cancer Screening Tests Product and Solutions
Table 29. Natera Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Natera Recent Developments and Future Plans
Table 31. Foresight Diagnostics Company Information, Head Office, and Major Competitors
Table 32. Foresight Diagnostics Major Business
Table 33. Foresight Diagnostics Blood-based Cancer Screening Tests Product and Solutions
Table 34. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Foresight Diagnostics Recent Developments and Future Plans
Table 36. Burning Rock Biotech Company Information, Head Office, and Major Competitors
Table 37. Burning Rock Biotech Major Business
Table 38. Burning Rock Biotech Blood-based Cancer Screening Tests Product and Solutions
Table 39. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Burning Rock Biotech Recent Developments and Future Plans
Table 41. Genetron Health Company Information, Head Office, and Major Competitors
Table 42. Genetron Health Major Business
Table 43. Genetron Health Blood-based Cancer Screening Tests Product and Solutions
Table 44. Genetron Health Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Genetron Health Recent Developments and Future Plans
Table 46. Singlera Genomics Company Information, Head Office, and Major Competitors
Table 47. Singlera Genomics Major Business
Table 48. Singlera Genomics Blood-based Cancer Screening Tests Product and Solutions
Table 49. Singlera Genomics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Singlera Genomics Recent Developments and Future Plans
Table 51. Berry Oncology Company Information, Head Office, and Major Competitors
Table 52. Berry Oncology Major Business
Table 53. Berry Oncology Blood-based Cancer Screening Tests Product and Solutions
Table 54. Berry Oncology Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Berry Oncology Recent Developments and Future Plans
Table 56. Helio Genomics Company Information, Head Office, and Major Competitors
Table 57. Helio Genomics Major Business
Table 58. Helio Genomics Blood-based Cancer Screening Tests Product and Solutions
Table 59. Helio Genomics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Helio Genomics Recent Developments and Future Plans
Table 61. Sysmex Company Information, Head Office, and Major Competitors
Table 62. Sysmex Major Business
Table 63. Sysmex Blood-based Cancer Screening Tests Product and Solutions
Table 64. Sysmex Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sysmex Recent Developments and Future Plans
Table 66. Global Blood-based Cancer Screening Tests Revenue (USD Million) by Players (2021-2026)
Table 67. Global Blood-based Cancer Screening Tests Revenue Share by Players (2021-2026)
Table 68. Breakdown of Blood-based Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3)
Table 69. Market Position of Players in Blood-based Cancer Screening Tests, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 70. Head Office of Key Blood-based Cancer Screening Tests Players
Table 71. Blood-based Cancer Screening Tests Market: Company Product Type Footprint
Table 72. Blood-based Cancer Screening Tests Market: Company Product Application Footprint
Table 73. Blood-based Cancer Screening Tests New Market Entrants and Barriers to Market Entry
Table 74. Blood-based Cancer Screening Tests Mergers, Acquisition, Agreements, and Collaborations
Table 75. Global Blood-based Cancer Screening Tests Consumption Value (USD Million) by Type (2021-2026)
Table 76. Global Blood-based Cancer Screening Tests Consumption Value Share by Type (2021-2026)
Table 77. Global Blood-based Cancer Screening Tests Consumption Value Forecast by Type (2027-2032)
Table 78. Global Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026)
Table 79. Global Blood-based Cancer Screening Tests Consumption Value Forecast by Application (2027-2032)
Table 80. North America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 81. North America Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 82. North America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 83. North America Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 84. North America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 87. Europe Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 88. Europe Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 89. Europe Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 90. Europe Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Europe Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 97. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 98. South America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 99. South America Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 100. South America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 101. South America Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 102. South America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 103. South America Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 104. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 105. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 106. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 107. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 108. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Global Key Players of Blood-based Cancer Screening Tests Upstream (Raw Materials)
Table 111. Global Blood-based Cancer Screening Tests Typical Customers
Table 1. Global Blood-based Cancer Screening Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Blood-based Cancer Screening Tests Consumption Value by Biomarker, (USD Million), 2021 & 2025 & 2032
Table 3. Global Blood-based Cancer Screening Tests Consumption Value by Test Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Blood-based Cancer Screening Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Blood-based Cancer Screening Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GRAIL Company Information, Head Office, and Major Competitors
Table 8. GRAIL Major Business
Table 9. GRAIL Blood-based Cancer Screening Tests Product and Solutions
Table 10. GRAIL Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GRAIL Recent Developments and Future Plans
Table 12. Guardant Health Company Information, Head Office, and Major Competitors
Table 13. Guardant Health Major Business
Table 14. Guardant Health Blood-based Cancer Screening Tests Product and Solutions
Table 15. Guardant Health Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Guardant Health Recent Developments and Future Plans
Table 17. Exact Sciences Company Information, Head Office, and Major Competitors
Table 18. Exact Sciences Major Business
Table 19. Exact Sciences Blood-based Cancer Screening Tests Product and Solutions
Table 20. Exact Sciences Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Freenome Company Information, Head Office, and Major Competitors
Table 22. Freenome Major Business
Table 23. Freenome Blood-based Cancer Screening Tests Product and Solutions
Table 24. Freenome Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Freenome Recent Developments and Future Plans
Table 26. Natera Company Information, Head Office, and Major Competitors
Table 27. Natera Major Business
Table 28. Natera Blood-based Cancer Screening Tests Product and Solutions
Table 29. Natera Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Natera Recent Developments and Future Plans
Table 31. Foresight Diagnostics Company Information, Head Office, and Major Competitors
Table 32. Foresight Diagnostics Major Business
Table 33. Foresight Diagnostics Blood-based Cancer Screening Tests Product and Solutions
Table 34. Foresight Diagnostics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Foresight Diagnostics Recent Developments and Future Plans
Table 36. Burning Rock Biotech Company Information, Head Office, and Major Competitors
Table 37. Burning Rock Biotech Major Business
Table 38. Burning Rock Biotech Blood-based Cancer Screening Tests Product and Solutions
Table 39. Burning Rock Biotech Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Burning Rock Biotech Recent Developments and Future Plans
Table 41. Genetron Health Company Information, Head Office, and Major Competitors
Table 42. Genetron Health Major Business
Table 43. Genetron Health Blood-based Cancer Screening Tests Product and Solutions
Table 44. Genetron Health Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Genetron Health Recent Developments and Future Plans
Table 46. Singlera Genomics Company Information, Head Office, and Major Competitors
Table 47. Singlera Genomics Major Business
Table 48. Singlera Genomics Blood-based Cancer Screening Tests Product and Solutions
Table 49. Singlera Genomics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Singlera Genomics Recent Developments and Future Plans
Table 51. Berry Oncology Company Information, Head Office, and Major Competitors
Table 52. Berry Oncology Major Business
Table 53. Berry Oncology Blood-based Cancer Screening Tests Product and Solutions
Table 54. Berry Oncology Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Berry Oncology Recent Developments and Future Plans
Table 56. Helio Genomics Company Information, Head Office, and Major Competitors
Table 57. Helio Genomics Major Business
Table 58. Helio Genomics Blood-based Cancer Screening Tests Product and Solutions
Table 59. Helio Genomics Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Helio Genomics Recent Developments and Future Plans
Table 61. Sysmex Company Information, Head Office, and Major Competitors
Table 62. Sysmex Major Business
Table 63. Sysmex Blood-based Cancer Screening Tests Product and Solutions
Table 64. Sysmex Blood-based Cancer Screening Tests Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sysmex Recent Developments and Future Plans
Table 66. Global Blood-based Cancer Screening Tests Revenue (USD Million) by Players (2021-2026)
Table 67. Global Blood-based Cancer Screening Tests Revenue Share by Players (2021-2026)
Table 68. Breakdown of Blood-based Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3)
Table 69. Market Position of Players in Blood-based Cancer Screening Tests, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 70. Head Office of Key Blood-based Cancer Screening Tests Players
Table 71. Blood-based Cancer Screening Tests Market: Company Product Type Footprint
Table 72. Blood-based Cancer Screening Tests Market: Company Product Application Footprint
Table 73. Blood-based Cancer Screening Tests New Market Entrants and Barriers to Market Entry
Table 74. Blood-based Cancer Screening Tests Mergers, Acquisition, Agreements, and Collaborations
Table 75. Global Blood-based Cancer Screening Tests Consumption Value (USD Million) by Type (2021-2026)
Table 76. Global Blood-based Cancer Screening Tests Consumption Value Share by Type (2021-2026)
Table 77. Global Blood-based Cancer Screening Tests Consumption Value Forecast by Type (2027-2032)
Table 78. Global Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026)
Table 79. Global Blood-based Cancer Screening Tests Consumption Value Forecast by Application (2027-2032)
Table 80. North America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 81. North America Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 82. North America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 83. North America Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 84. North America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 85. North America Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Europe Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 87. Europe Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 88. Europe Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 89. Europe Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 90. Europe Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 91. Europe Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2021-2026) & (USD Million)
Table 97. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value by Region (2027-2032) & (USD Million)
Table 98. South America Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 99. South America Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 100. South America Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 101. South America Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 102. South America Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 103. South America Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 104. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2021-2026) & (USD Million)
Table 105. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Type (2027-2032) & (USD Million)
Table 106. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2021-2026) & (USD Million)
Table 107. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Application (2027-2032) & (USD Million)
Table 108. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value by Country (2027-2032) & (USD Million)
Table 110. Global Key Players of Blood-based Cancer Screening Tests Upstream (Raw Materials)
Table 111. Global Blood-based Cancer Screening Tests Typical Customers
LIST OF FIGURES
Figure 1. Blood-based Cancer Screening Tests Picture
Figure 2. Global Blood-based Cancer Screening Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Type in 2025
Figure 4. Single-cancer Screening
Figure 5. Multi-cancer Early Detection
Figure 6. Colorectal Cancer Screening
Figure 7. Liver Cancer Screening
Figure 8. Lung Cancer Screening
Figure 9. Risk Stratification Test
Figure 10. Other
Figure 11. Global Blood-based Cancer Screening Tests Consumption Value by Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Biomarker in 2025
Figure 13. cfDNA Methylation
Figure 14. ctDNA Mutation
Figure 15. Fragmentomics
Figure 16. Protein Biomarkers
Figure 17. Multi-omics
Figure 18. Exosome-based
Figure 19. Other
Figure 20. Global Blood-based Cancer Screening Tests Consumption Value by Test Format, (USD Million), 2021 & 2025 & 2032
Figure 21. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Test Format in 2025
Figure 22. Laboratory-developed Test
Figure 23. IVD Kit
Figure 24. Sequencing-based
Figure 25. PCR-based
Figure 26. Immunoassay-based
Figure 27. Other
Figure 28. Global Blood-based Cancer Screening Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 29. Blood-based Cancer Screening Tests Consumption Value Market Share by Application in 2025
Figure 30. Health Check-up Centers Picture
Figure 31. Hospitals Picture
Figure 32. Independent Clinical Laboratories Picture
Figure 33. Other Picture
Figure 34. Global Blood-based Cancer Screening Tests Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global Blood-based Cancer Screening Tests Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Market Blood-based Cancer Screening Tests Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 37. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 38. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Region in 2025
Figure 39. North America Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 42. South America Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 44. Company Three Recent Developments and Future Plans
Figure 45. Global Blood-based Cancer Screening Tests Revenue Share by Players in 2025
Figure 46. Blood-based Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 47. Market Share of Blood-based Cancer Screening Tests by Player Revenue in 2025
Figure 48. Top 3 Blood-based Cancer Screening Tests Players Market Share in 2025
Figure 49. Top 6 Blood-based Cancer Screening Tests Players Market Share in 2025
Figure 50. Global Blood-based Cancer Screening Tests Consumption Value Share by Type (2021-2026)
Figure 51. Global Blood-based Cancer Screening Tests Market Share Forecast by Type (2027-2032)
Figure 52. Global Blood-based Cancer Screening Tests Consumption Value Share by Application (2021-2026)
Figure 53. Global Blood-based Cancer Screening Tests Market Share Forecast by Application (2027-2032)
Figure 54. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 55. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 56. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 57. United States Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 58. Canada Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 59. Mexico Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 60. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 61. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 62. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 63. Germany Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 64. France Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 65. United Kingdom Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 66. Russia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 67. Italy Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 68. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 69. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 70. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 71. China Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 74. India Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 77. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 78. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 79. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 83. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 84. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 87. UAE Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 88. Blood-based Cancer Screening Tests Market Drivers
Figure 89. Blood-based Cancer Screening Tests Market Restraints
Figure 90. Blood-based Cancer Screening Tests Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. Blood-based Cancer Screening Tests Industrial Chain
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. Blood-based Cancer Screening Tests Picture
Figure 2. Global Blood-based Cancer Screening Tests Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Type in 2025
Figure 4. Single-cancer Screening
Figure 5. Multi-cancer Early Detection
Figure 6. Colorectal Cancer Screening
Figure 7. Liver Cancer Screening
Figure 8. Lung Cancer Screening
Figure 9. Risk Stratification Test
Figure 10. Other
Figure 11. Global Blood-based Cancer Screening Tests Consumption Value by Biomarker, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Biomarker in 2025
Figure 13. cfDNA Methylation
Figure 14. ctDNA Mutation
Figure 15. Fragmentomics
Figure 16. Protein Biomarkers
Figure 17. Multi-omics
Figure 18. Exosome-based
Figure 19. Other
Figure 20. Global Blood-based Cancer Screening Tests Consumption Value by Test Format, (USD Million), 2021 & 2025 & 2032
Figure 21. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Test Format in 2025
Figure 22. Laboratory-developed Test
Figure 23. IVD Kit
Figure 24. Sequencing-based
Figure 25. PCR-based
Figure 26. Immunoassay-based
Figure 27. Other
Figure 28. Global Blood-based Cancer Screening Tests Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 29. Blood-based Cancer Screening Tests Consumption Value Market Share by Application in 2025
Figure 30. Health Check-up Centers Picture
Figure 31. Hospitals Picture
Figure 32. Independent Clinical Laboratories Picture
Figure 33. Other Picture
Figure 34. Global Blood-based Cancer Screening Tests Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global Blood-based Cancer Screening Tests Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Market Blood-based Cancer Screening Tests Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 37. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 38. Global Blood-based Cancer Screening Tests Consumption Value Market Share by Region in 2025
Figure 39. North America Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 42. South America Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 44. Company Three Recent Developments and Future Plans
Figure 45. Global Blood-based Cancer Screening Tests Revenue Share by Players in 2025
Figure 46. Blood-based Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 47. Market Share of Blood-based Cancer Screening Tests by Player Revenue in 2025
Figure 48. Top 3 Blood-based Cancer Screening Tests Players Market Share in 2025
Figure 49. Top 6 Blood-based Cancer Screening Tests Players Market Share in 2025
Figure 50. Global Blood-based Cancer Screening Tests Consumption Value Share by Type (2021-2026)
Figure 51. Global Blood-based Cancer Screening Tests Market Share Forecast by Type (2027-2032)
Figure 52. Global Blood-based Cancer Screening Tests Consumption Value Share by Application (2021-2026)
Figure 53. Global Blood-based Cancer Screening Tests Market Share Forecast by Application (2027-2032)
Figure 54. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 55. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 56. North America Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 57. United States Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 58. Canada Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 59. Mexico Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 60. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 61. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 62. Europe Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 63. Germany Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 64. France Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 65. United Kingdom Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 66. Russia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 67. Italy Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 68. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 69. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 70. Asia-Pacific Blood-based Cancer Screening Tests Consumption Value Market Share by Region (2021-2032)
Figure 71. China Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 74. India Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 77. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 78. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 79. South America Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Type (2021-2032)
Figure 83. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Application (2021-2032)
Figure 84. Middle East & Africa Blood-based Cancer Screening Tests Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 87. UAE Blood-based Cancer Screening Tests Consumption Value (2021-2032) & (USD Million)
Figure 88. Blood-based Cancer Screening Tests Market Drivers
Figure 89. Blood-based Cancer Screening Tests Market Restraints
Figure 90. Blood-based Cancer Screening Tests Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. Blood-based Cancer Screening Tests Industrial Chain
Figure 93. Methodology
Figure 94. Research Process and Data Source
